Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/9/2018
SIETES contiene 92557 citas

 
 
 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. BMJ 2018;362:k2693. [Ref.ID 102821]
2. Cita con resumen
Shin J-Y, Eberg M, Enrst P, Filion KB. Statin potency and the risk of hospitalization for community-acquired pneumonia. Br J Clin Pharmacol 2017;83:1319-27. [Ref.ID 101943]
3.Tiene citas relacionadas Cita con resumen
Azoulay L, Filion KB, Platt RW, Dormuth CR, Clemens KK, Durand M, Hu N, Juurlink DN, Paterson JM, Targownik LE, Turin TC, Ernst P, and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Association between incretin-based drugs and the risk of acute pancreatitis . JAMA Intern Med 2016:1 de octubre. [Ref.ID 100558]
4.Tiene citas relacionadas Cita con resumen
Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L. Pioglitazone use and risk of bladder cancer: population based cohort study.. BMJ 2016;352:i1541. [Ref.ID 100145]
5. Cita con resumen
Filion KB, Azoulay L, Platt RW, Dahl M, Dormuth CR, Clemens KK, Hu N, Paterson JM, Targownik L, Turin TC, Udell JA, Ernst P, for the CNODES Investigators. A multicenter observational study of incretin-based drugs and heart failure. N Engl J Med 2016;374:1145-54. [Ref.ID 100077]
6.Tiene citas relacionadas Cita con resumen
Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study. BMJ 2016;352:i581. [Ref.ID 100066]
7. Cita con resumen
Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases. BMJ 2014;348:g3244. [Ref.ID 98059]
8.Tiene citas relacionadas Cita con resumen
Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, Pollak MN, Suissa S. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-constrol study. BMJ 2012;344:15. [Ref.ID 93245]
9.Enlace a cita original Cita con resumen
Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 2012;110:453-60. [Ref.ID 92622]
10.Enlace a cita original
Azoulay L, Schneider-Lindner V, Dell'Aniello S, Filion KB, Suissa S. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a neste case-control study. Pharmacoepidemiol Drug Saf 2010;19:abril. [Ref.ID 88267]
11.Enlace a cita original
Filion KB, Joseph L, Boivin J-F, Suissa S, Brophy JM. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf 2009;18:973-6. [Ref.ID 86841]
12.Tiene citas relacionadas Cita con resumen
Schneider-Lindner V, Filion KB, Brophy JM. Adverse outcomes associated with use of proton pump inhibitors and clopidogrel. JAMA 2009;302:29-30. [Ref.ID 86151]
13.
Filion KB, Delaney JAC, Brophy JM, Ernst P, Suissa S. The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf 2007;16:1-4. [Ref.ID 79221]
Seleccionar todas
 
 1 a 13 de 13